TickerFacts.

Celldex Therapeutics, Inc. (CLDX): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.71M
Year ended 2025-12-31
$6.54M
Trailing 12 months to 2026-06-30
+14.1%
3-year compound annual growth
+11.8%
5-year compound annual growth
-5.7%
10-year compound annual growth
$4.88M2009-12-31: $528.0K2010-12-31: $2.10M2011-12-31: $509.0K2012-12-31: $303.0K2013-12-31: $4.22M2014-12-31: $1.93M2015-12-31: $4.88M2016-12-31: $2.75M2017-12-31: $1.79M2018-12-31: $813.0K2019-12-31: $731.0K2020-12-31: $1.55M2021-12-31: $1.25M2022-12-31: $1.83M2023-12-31: $1.82M2024-12-31: $1.92M2025-12-31: $2.71M$2.71M
2009-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.71M+41.4%2026-02-25, From 2025-01-01
2024-12-31$1.92M+5.6%2026-02-25, From 2024-01-01
2023-12-31$1.82M-0.5%2026-02-25, From 2023-01-01
2022-12-31$1.83M+46.4%2025-02-27, From 2022-01-01
2021-12-31$1.25M-19.5%2024-02-26, From 2021-01-01
2020-12-31$1.55M+112.3%2023-02-28, From 2020-01-01
2019-12-31$731.0K-10.1%2022-02-28, From 2019-01-01
2018-12-31$813.0K-54.5%2021-03-29, From 2018-01-01
2017-12-31$1.79M-35.0%2020-03-26, From 2017-01-01
2016-12-31$2.75M-43.6%2019-03-07, From 2016-01-01
2015-12-31$4.88M+152.8%2018-03-07, From 2015-01-01
2014-12-31$1.93M-54.3%2017-03-14, From 2014-01-01
2013-12-31$4.22Mn/m2016-02-25, From 2013-01-01
2012-12-31$303.0K-40.5%2015-02-24, From 2012-01-01
2011-12-31$509.0K-75.8%2014-03-03, From 2011-01-01
2010-12-31$2.10M+297.7%2013-03-08, From 2010-01-01
2009-12-31$528.0Kn/a2012-03-08, From 2009-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Celldex Therapeutics, Inc. (CLDX)2025-12-31$2.71M+41.4%
Volitionrx Ltd (VNRX)2025-12-31$89.6K-67.7%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$3.19M+517.2%
Aspira Women's Health Inc. (AWHL)2025-12-31$16.0K-56.8%
Immucell Corp (ICCC)2025-12-31$1.25M+168.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$1.15M+2.0%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$1.13M-80.5%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$187.3K-12.8%
Neogen Corp (NEOG)2026-05-31$51.30M-51.0%

Compare CLDX, VNRX, IMDX, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗